Humedix announced on the 14th that its hyaluronic acid (HA) filler 'Elravie Premier' has obtained product approval from the Russian Federal Service for Surveillance in Healthcare (Roszdravnadzor).


Humedics Elavie Premier Soft. [Photo by Humedics]

Humedics Elavie Premier Soft. [Photo by Humedics]

View original image

The products approved in Russia this time include five types: ▲Elravie Premier Light-L ▲Elravie Premier Deep Line-L ▲Elravie Premier Ultra Volume Line-L (1㎖/2㎖) ▲Elravie Balance, and others.


Elravie Premier is a domestic filler brand made using Humedix's proprietary high-purity crosslinked hyaluronic acid production technology. It applies the Hi-B (High Viscoelasticity-Hybrid) method to ensure stability and enhances crosslinking efficiency to maintain the viscosity of hyaluronic acid. Elravie Premier has obtained approval not only in Korea but also certifications such as the European CE, China’s National Medical Products Administration (NMPA), and now Russia.



Starting with this Russian product approval, Humedix plans to promote the quality and stability of its HA fillers in the global market and expand its influence. A Humedix official stated, "We are pleased to be able to showcase the excellent quality and technology of Elravie Premier hyaluronic acid filler to the global market through the Russian approval," adding, "We will continue to make sustained efforts to further expand our influence in overseas markets."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing